About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Denver | 341 Studies

Clinical Trials Breast CancerDenver

Breast Cancer Clinical Trials in Denver

Find 341 clinical trials for breast cancer near Denver, Colorado. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Denver

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 141-160 of 341 trials

TerminatedAspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation TherapyThis randomized phase III trial studies how well aspirin works in preventing the cancer from coming back (recurrence) in patients with human epidermal growth factor receptor 2…NCT02927249·Birmingham, Alabama and 1451 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingAssessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology ClinicsThis is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are…NCT06418204·Fairbanks, Alaska and 490 others

RecruitingA Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid TumorsThis is a Phase 1, two-part, open-label, nonrandomized, dose-escalation and signal-seeking study of CGT6297, evaluating the safety, tolerability, PK, pharmacodynamic (what the…NCT07383506·Scottsdale, Arizona and 11 others

CompletedE7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast CancerThe purpose of this study is to compare Overall Survival (OS), Progression Free Survival (PFS), objective tumor response rate, duration of response, and safety in patients treated…NCT00388726·Birmingham, Alabama and 136 others

CompletedS0812 High Dose Cholecalciferol in Premenopausal Women at High-Risk for Breast CancerRATIONALE: Cholecalciferol may prevent breast cancer in premenopausal women.NCT01097278·Anniston, Alabama and 359 others

CompletedLetrozole in Treating Postmenopausal Women With Ductal Carcinoma in SituRATIONALE: Estrogen can cause the growth of breast cancer cells.NCT01439711·Los Angeles, California and 31 others

CompletedA Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid TumorsThis is a first-in-human, open-label, dose escalation study to evaluate the safety and tolerability of pegilodecakin in participants with advanced solid tumors, dosed daily…NCT02009449·Los Angeles, California and 9 others

CompletedAn Observational Study in Patients With HER2 Positive Metastatic Breast Cancer (SystHERs Registry)This multi-center, prospective observational study will evaluate the treatment patterns, and the safety in patients with HER2-positive (HER2+) metastatic breast cancer (MBC).NCT01615068·Birmingham, Alabama and 141 others

CompletedDrug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast CancerThe purpose of this study is to determine the effect of exemestane on the pharmacokinetics (PK) of entinostat and to determine the effect of entinostat on the PK of exemestane in…NCT02820961·Denver, Colorado and 2 others

CompletedStudy of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast CancerPhase 1 of this study will evaluate the maximum tolerated dose (MTD) of XL147 when given in combination with letrozole (Femara) and of XL765 when given in combination with…NCT01082068·Los Angeles, California and 16 others

CompletedRisedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast CancerRATIONALE: Preventing bone loss in patients who are receiving chemotherapy for breast cancer may decrease the risk of fractures and may help patients live more comfortably.NCT00054418·Mobile, Alabama and 198 others

CompletedUltrasound Elastography of Breast LesionsOur hypothesis is that the addition of ShearWave Elastography (SWE) to a conventional breast ultrasound examination provides useful information for the radiologist when imaging…NCT00716482·Los Angeles, California and 15 others

CompletedPhase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase InhibitorThis study was a multi-center, randomized, double-blind, placebo controlled Phase III study to determine the efficacy and safety of treatment with buparlisib plus fulvestrant…NCT01610284·Mobile, Alabama and 267 others

Active not recruitingA Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)This Phase III, randomized, double-blind, placebo-controlled, multicenter study will evaluate the efficacy and safety of giredestrant combined with palbociclib compared with…NCT04546009·Fountain Valley, California and 255 others

RecruitingA Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsThe goal of the Monotherapy Dose Escalation phase (Part 1) of the study is to evaluate the safety, tolerability, pharmacokinetics (PK) and preliminary anti-tumor activity to…NCT06586957·Little Rock, Arkansas and 20 others

CompletedStudy of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast CancerObjective: To determine the Overall Response Rate (ORR) to Imprime PGG + pembrolizumab in subjects with advanced melanoma or metastatic TNBC Safety: To characterize the safety of…NCT02981303·Avondale, Arizona and 9 others

UnknownLiposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00027989·Montgomery, Alabama and 5 others

Active not recruitingPhII ICb With/Without Erbitux in MBC PtsThe purpose of this study is to determine the objective response rates produced by irinotecan and carboplatin therapy with or without Erbitux in patients with Metastatic Breast…NCT00248287·Birmingham, Alabama and 58 others

Active not recruitingTesting Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain MetastasesThis phase II trial studies the effect of sacituzumab govitecan in treating patients with HER2-negative breast cancer that has spread to the brain (brain metastases).NCT04647916·Anchorage, Alaska and 295 others

CompletedS0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast CancerRATIONALE: Estrogen can stimulate the growth of breast cancer cells.NCT00075764·Anniston, Alabama and 425 others

PreviousPage 8 of 18Next

Other Conditions in Denver

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma